Divine Aleru, Microbiome Medicine Research Coordinator

This study investigates EPS-rich biofilm dynamics, showing how biofilm dispersal via DNase and EPS-glycosidases influences microbial community structure and resilience. It highlights the role of commensal reseeding in restoring microbial balance after dispersal.

This study demonstrates that Vibrio harveyi regulates lead precipitation through quorum-sensing systems, particularly AI1, AI2, and a newly discovered AI3, with implications for environmental bioremediation and microbial interactions in metal-contaminated environments.

This study demonstrates that Cd(II) and Pb(II) induce zntA expression in E. coli through ZntR, highlighting the importance of ZntA in metal resistance and the potential for therapeutic applications targeting metal transporters.

The study of the Ralstonia metallidurans pbr operon reveals mechanisms of lead resistance, highlighting Pb(II) uptake, efflux, and sequestration, and offering potential applications in bioremediation and therapeutic strategies for lead poisoning.

This review defines how lead binding in proteins drives host enzyme inhibition and signaling errors while microbial operons export and precipitate Pb(II), reshaping niche metal availability and competitive fitness.

A comprehensive review of Deferoxamine B metal chelator links siderophore chemistry, microbial uptake, and clinical chelation/imaging, highlighting speciation across metals—including Pb(II)—and implications for microbiome-related metal competition.

An in vivo radiotracer study defines lead absorption and excretion in the rat: duodenal, bile-modulated uptake; competition with Fe/Zn/Ca; iron deficiency–enhanced absorption; erythrocyte transport; early renal–hepatic handling; biliary plus urinary clearance; and bone storage.

A mechanistic review links heavy metals and human health to dysbiosis via protein-binding competition, redox injury, epithelial leak, and LPS-driven inflammation, outlining organ toxicity and clinical chelation strategies.

Premenstrual Dysphoric Disorder (PMDD) is a severe mood disorder linked to hormonal and neurochemical changes. Emerging research highlights the gut microbiome’s role in symptom modulation, opening new avenues for microbiome-targeted treatments alongside traditional therapies.

This review discusses the toxicological impact of heavy metals like arsenic, cadmium, and mercury on human health, particularly their interaction with proteins and enzymes, leading to various disorders and potential carcinogenesis. Detoxification strategies and the importance of environmental cleanup are also highlighted.

The study highlights the cooperation between the PbrA efflux pump and PbrB phosphatase in the detoxification of lead, uncovering a novel mechanism for lead resistance in Cupriavidus metallidurans. This research suggests potential bioremediation applications and deeper insights into microbial heavy metal resistance mechanisms.

This study sheds light on the molecular mechanisms through which Cupriavidus metallidurans CH34 regulates lead resistance, highlighting the role of the PbrR protein and its interaction with the PpbrA promoter in response to Pb(II).

This study demonstrates that lead exposure disrupts the gut microbiome, reducing microbial diversity and impairing key metabolic pathways related to vitamin E, bile acids, nitrogen metabolism, and energy metabolism. These disruptions may contribute to lead toxicity and associated diseases.

This review maps mechanisms and taxa underlying lead bioremediation by bacteria, linking microbial toolkits (EPS, phosphatases, sulfate reducers, PIB-ATPases, metallothioneins) to field performance and clinical microbiome relevance, and guiding signature curation and remediation design.

The review examines the neurotoxic effects of lead exposure, focusing on mechanisms such as ion mimicry, mitochondrial dysfunction, and neuroinflammation. It emphasizes the long-term impact of lead on cognitive function and behavior and discusses biomarkers for assessing lead exposure and its effects on the brain.

This review explores the molecular mechanisms of lead neurotoxicity, focusing on ion mimicry, mitochondrial dysfunction, oxidative stress, and neuroinflammation. The findings emphasize the long-term cognitive and behavioral effects of lead exposure, with implications for clinical intervention and microbiome-related research.

The review highlights the connection between lead exposure and osteoporosis risk in post-menopausal women, showing how lead release during bone turnover contributes to health complications. Strategies to reduce bone resorption during menopause can mitigate lead-related risks and improve health outcomes.

CDC lowered the pediatric BLRV to 3.5 µg/dL, enabling earlier action, clarifying disparities, and setting exposure tiers that should guide microbiome signature curation at contemporary low BLLs.

Meta-analysis shows ALAD polymorphism and lead interactions: ALAD2 raises BLL in workers, lowers chelatable lead, and slightly improves heme indices; bone lead is unchanged.

Clinician summary of prenatal lead exposure and gut microbiome links at age 9–11 in PROGRESS: negative mixture effects, trimester-specific taxa shifts, and a potential second-trimester sensitivity window.

A clinician-focused review updates present-day lead exposure risks and microbiome implications, contrasting older population metrics with SPHERL’s prospective data and outlining how exposure tiers, co-exposures, and confounding shape credible microbiome–lead signatures.

NICE guidance recommends diagnosing menopause in women over 45 clinically, not with lab tests, while FSH measurement is reserved for suspected POI in women under 40, streamlining care and reducing unnecessary testing in clinical biochemistry laboratories.

Hormone Replacement Therapy (HRT) is one of the most effective treatments for women experiencing the symptoms of menopause, particularly vasomotor symptoms such as hot flashes and night sweats. But its benefits go beyond just symptom management. HRT can also play a key role in improving vaginal health by alleviating dryness and discomfort, which are common complaints among women in menopause. Additionally, it helps prevent bone loss, significantly reducing the risk of osteoporosis and fractures, which are more common after menopause. Despite its many benefits, HRT is not one-size-fits-all; it’s essential to tailor treatment based on individual health profiles, taking into account the risks like breast cancer, blood clots, and heart disease that come with prolonged use.

Ospemifene is an effective and safe treatment for menopausal vaginal dryness and dyspareunia, particularly in women with contraindications for estrogen therapy. It improves vaginal health without significantly affecting systemic hormone levels, providing an alternative treatment for genitourinary syndrome of menopause.